Literature DB >> 19822373

Comparison of gating around end-expiration and end-inspiration in radiotherapy for lung cancer.

Tetsuo Saito1, Takashi Sakamoto, Natsuo Oya.   

Abstract

PURPOSE: To evaluate the advantages and disadvantages of gating around end-expiration and end-inspiration.
MATERIALS AND METHODS: We created five irradiation protocols to treat 15 patients with lung cancer. They were non-gated irradiation (protocol 1, P1), amplitude-based gating around end-expiration (P2) and end-inspiration (P3), and phase-based gating around end-expiration (P4) and end-inspiration (P5). We compared the lung dosimetric parameters and the treatment time.
RESULTS: Compared to P2, in P3 the mean lung dose was reduced by 0.5+/-0.4Gy, V20 by 1.2+/-0.9%, V10 by 1.4+/-0.8%, and V5 by 1.5+/-0.9% (p<0.01). There was no statistically significant difference in these parameters between P4 and P5. At a dose rate of 600 monitor units/min (MUs/min), the average treatment time required for 100MUs was 10, 26, 64, 33, and 33 s, respectively, for P1, P2, P3, P4, and P5.
CONCLUSIONS: With amplitude-based gating, gating around end-inspiration (P3) produced a greater decrease in the lung dose, however, the treatment time was longest among the four gated protocols. There was no significant difference between the two phase-based gating protocols (P4 and P5) with respect to the radiation dose to the lungs and the treatment time.

Entities:  

Mesh:

Year:  2009        PMID: 19822373     DOI: 10.1016/j.radonc.2009.09.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.

Authors:  Anna Simeonova-Chergou; Anika Jahnke; Kerstin Siebenlist; Florian Stieler; Sabine Mai; Judit Boda-Heggemann; Frederik Wenz; Frank Lohr; Lennart Jahnke
Journal:  Strahlenther Onkol       Date:  2016-01-15       Impact factor: 3.621

2.  Three-dimensional conformal radiotherapy by delineations on CT-based simulation in different respiratory phases for the treatment of senile patients with non-small cell lung cancer.

Authors:  Weifeng Wang; Feng Yuan; Guoping Wang; Zhiren Lin; Yanling Pan; Longhua Chen
Journal:  Onco Targets Ther       Date:  2015-09-07       Impact factor: 4.147

3.  Respiratory gating during stereotactic body radiotherapy for lung cancer reduces tumor position variability.

Authors:  Tetsuo Saito; Tomohiko Matsuyama; Ryo Toya; Yoshiyuki Fukugawa; Takamasa Toyofuku; Akiko Semba; Natsuo Oya
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

Review 4.  [Advances of precise radiotherapy for lung cancer].

Authors:  Xin Wang; Feng Xu; Yuquan Wei
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-11

5.  Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC).

Authors:  K M Kraus; M Oechsner; J J Wilkens; K A Kessel; S Münch; S E Combs
Journal:  Sci Rep       Date:  2021-03-12       Impact factor: 4.379

6.  Comparison of Phase-Gated and Amplitude-Gated Dose Delivery to a Moving Target using Gafchromic EBT3 Film.

Authors:  Milovan Savanović; Dražan Jaroš; Jean Noel Foulquier
Journal:  J Med Phys       Date:  2021-08-07

7.  A transit portal dosimetry method for respiratory gating quality assurance with a dynamic 3D printed tumor phantom.

Authors:  Hong Qi Tan; Calvin Wei Yang Koh; Lloyd Kuan Rui Tan; Kah Seng Lew; Clifford Ghee Ann Chua; Khong Wei Ang; James Cheow Lei Lee; Sung Yong Park
Journal:  J Appl Clin Med Phys       Date:  2022-02-11       Impact factor: 2.243

8.  To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.

Authors:  Joshua Kim; Qixue Wu; Bo Zhao; Ning Wen; Munther Ajlouni; Benjamin Movsas; Indrin J Chetty
Journal:  Radiat Oncol       Date:  2016-09-22       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.